H3D(@H3D_UCT) 's Twitter Profileg
H3D

@H3D_UCT

H3D is the first and only centre of its kind on the African continent, an integrated drug discovery and development centre with TB, malaria and AMR platforms

ID:1317771709076865025

calendar_today18-10-2020 10:17:30

631 Tweets

809 Followers

168 Following

Miquel Duran Frigola(@mduranfrigola) 's Twitter Profile Photo

Proud of this comment article in nature jointly written by H3D & Ersilia. We discuss how (low-data) AI can aid pharmacogenetics in Africa. We are actively working on this, so there's more to come!
Thanks Gemma Turon Kelly Chibale Mwila & Mathew!
nature.com/articles/d4158…

account_circle
H3D(@H3D_UCT) 's Twitter Profile Photo

In this review, Vinayak Singh describes strategies for shortening the intolerably long treatment regimens for (currently 4–9 months for subsceptible strains!), important both for patients and global TB management: sciencedirect.com/science/articl… 💊 UCT IDM

account_circle
H3D Foundation(@H3D_Foundation) 's Twitter Profile Photo

Join us for our next webinar this Wednesday at 2pm (SAST)

Dr Tai Yue from Medicines for All will be presenting on pharmaceutical process chemistry.

Join via this Microsoft Teams: lnkd.in/d6yEnFhB

Info: [email protected] or [email protected]

Join us for our next webinar this Wednesday at 2pm (SAST) Dr Tai Yue from @MedsforAll will be presenting on pharmaceutical process chemistry. Join via this Microsoft Teams: lnkd.in/d6yEnFhB Info: john.woodland@uct.ac.za or susan.winks@uct.ac.za
account_circle
H3D(@H3D_UCT) 's Twitter Profile Photo

New paper in ! To address the cardiotoxicity of the antimalarial astemizole, Dickson Mambwe et al. report a compound with multistage activity and a >6 000-fold selectivity against hERG relative to astemizole. No cross-resistance was observed pubs.acs.org/doi/10.1021/ac…

account_circle
H3D Foundation(@H3D_Foundation) 's Twitter Profile Photo

Today, we mark .

An initiative of World Health Organization (WHO), the theme for is ‘Yes! You and I Can End TB’.

As avid supporters of TB drug discovery research, this is a statement we firmly believe in and strive to realise.

Read more:

h3dfoundation.org/world-tb-day-h…

Today, we mark #WorldTuberculosisDay. An initiative of @WHO, the theme for #WorldTBDay2024 is ‘Yes! You and I Can End TB’. As avid supporters of TB drug discovery research, this is a statement we firmly believe in and strive to realise. Read more: h3dfoundation.org/world-tb-day-h…
account_circle
H3D(@H3D_UCT) 's Twitter Profile Photo

H3D is hiring! H3D is seeking to appoint an experienced Artificial Intelligence and Machine Learning (AI/ML) Investigator on a 3-year contract. lnkd.in/d8mm3vu7 /ML

H3D is hiring! H3D is seeking to appoint an experienced Artificial Intelligence and Machine Learning (AI/ML) Investigator on a 3-year contract. lnkd.in/d8mm3vu7 #drugdiscovery #vacancy #AI/ML
account_circle
H3D Foundation(@H3D_Foundation) 's Twitter Profile Photo

Thank you UCT for this great feature about the major funding boost the Grand Challenges African Drug Discovery Accelerator (GC ADDA) network received from LifeArc and Gates Foundation

news.uct.ac.za/article/-2024-…

account_circle
H3D(@H3D_UCT) 's Twitter Profile Photo

Maximise your chances of getting your medicinal chemistry-based manuscript accepted for publication! In a new editorial in , Editor-in-Chief Kelly Chibale and John Woodland share their top tips for prospective authors: pubs.acs.org/doi/10.1021/ac… UCT IDM @UCT_News

account_circle
H3D(@H3D_UCT) 's Twitter Profile Photo

'Our plans [for the future] are to catalyze job creation by driving the expansion of Africa’s community and ecosystem.' Dive into a wide-ranging interview with Kelly Chibale in the World Intellectual Property Organization (WIPO) Newsletter! wipo.int/wipo_magazine_…

account_circle
H3D Foundation(@H3D_Foundation) 's Twitter Profile Photo

Join us for our first webinar of the year on Wednesday, 14 February at 12PM

Dr Barry Hardy , Managing Director (CEO) at Edelweiss Connect, Switzerland will be discussing how integrated analysis can support prediction of drug adverse outcomes.

Webinar link: bit.ly/3wkdAHd

Join us for our first webinar of the year on Wednesday, 14 February at 12PM Dr @barryhardy , Managing Director (CEO) at @EdelweissConn, Switzerland will be discussing how integrated analysis can support prediction of drug adverse outcomes. Webinar link: bit.ly/3wkdAHd
account_circle
H3D(@H3D_UCT) 's Twitter Profile Photo

Only 3 days left to get your abstract and travel bursary applications in! Don't miss your opportunity! Apply now to ensure you can attend the 5th H3D Symposium at the unforgettable Radisson Blu Mosi-Oa-Tunya, Livingstone Resort, Zambia. lnkd.in/ex6PZk_f

Only 3 days left to get your abstract and travel bursary applications in! Don't miss your opportunity! Apply now to ensure you can attend the 5th H3D Symposium at the unforgettable Radisson Blu Mosi-Oa-Tunya, Livingstone Resort, Zambia. lnkd.in/ex6PZk_f
account_circle
H3D(@H3D_UCT) 's Twitter Profile Photo

3 Months to go! Register now for the 5th H3D Symposium!
Abstract submission and travel bursary submission closes on 31st Jan 2024, don't miss your opportunity to present your research! linkedin.com/feed/update/ur…

3 Months to go! Register now for the 5th H3D Symposium! Abstract submission and travel bursary submission closes on 31st Jan 2024, don't miss your opportunity to present your research! linkedin.com/feed/update/ur… #H3DSymposium #drugdiscovery
account_circle
H3D(@H3D_UCT) 's Twitter Profile Photo

H3D is hiring! Do you have a PhD in microbiology, molecular Biology, Biochemistry, Genetics or Cell Biology? See below for more information h3d.uct.ac.za/open-positions

H3D is hiring! Do you have a PhD in microbiology, molecular Biology, Biochemistry, Genetics or Cell Biology? See below for more information h3d.uct.ac.za/open-positions #drugdiscovery #vacancies
account_circle